In Response

Affiliations

Comment

Samuel Zagarella. Am J Dermatopathol. 2021.

. 2021 Jul 1;43(7):541-542.

doi: 10.1097/DAD.0000000000001828.

¹ Department of Medicine, Concord Hospital, University of Sydney, Sydney, Australia.

No abstract available

Conflict of interest statement

The author declares no conflicts of interest.

Letter Regarding Editorial by Samuel Zagarella.
Faries MB, Ascierto PA, Blank C, Cochran AJ, Delman K, Gyorki D, Haanen J, Hamid O, Han D, Karakousis G, Kashani-Sabet M, Leachman S, Moncrieff M, Plasmeijer E, Enrico Testori AA, Van Akkooi A, Wong S, Zager JS. Faries MB, et al. Am J Dermatopathol. 2021 Jul 1;43(7):539-541. doi: 10.1097/DAD.0000000000001857. Am J Dermatopathol. 2021. PMID: 33264129 No abstract available.

1. Faries M, Ascierto P, et al. Letter to the editor regarding Zagarella editorial [epub ahead of print].
1. Sladden M, Zagarella S, Popescu C, et al. No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the multicenter selective lymphadenectomy trial-1 final report. Br J Derm. 2015;172:566–573.
1. Extramural committee to assess measurements of progress against cancer. Measurement of progress against cancer. J Natl Cancer Inst. 1990;82:825–835.
1. Bamboat Z, Konstantinidis IT, Kuk D, et al. Observation after a positive sentinel lymph node biopsy in patients with melanoma. Ann Surg Oncol. 2014;21:3117–3123.
1. Daniel C. The enigma of regional nodes in melanoma. N Engl J Med. 2017;376:2280–2281.